Literature DB >> 24832450

Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria.

Hong Zhao1, Taiki Aoshi2, Satoru Kawai3, Yuki Mori4, Aki Konishi1, Muge Ozkan1, Yukiko Fujita1, Yasunari Haseda5, Mikiko Shimizu1, Masako Kohyama6, Kouji Kobiyama2, Kei Eto7, Junichi Nabekura7, Toshihiro Horii8, Tomoko Ishino9, Masao Yuda9, Hiroaki Hemmi10, Tsuneyasu Kaisho10, Shizuo Akira11, Manabu Kinoshita12, Koujiro Tohyama13, Yoshichika Yoshioka4, Ken J Ishii2, Cevayir Coban14.   

Abstract

Cerebral malaria is a complication of Plasmodium falciparum infection characterized by sudden coma, death, or neurodisability. Studies using a mouse model of experimental cerebral malaria (ECM) have indicated that blood-brain barrier disruption and CD8 T cell recruitment contribute to disease, but the spatiotemporal mechanisms are poorly understood. We show by ultra-high-field MRI and multiphoton microscopy that the olfactory bulb is physically and functionally damaged (loss of smell) by Plasmodium parasites during ECM. The trabecular small capillaries comprising the olfactory bulb show parasite accumulation and cell occlusion followed by microbleeding, events associated with high fever and cytokine storm. Specifically, the olfactory upregulates chemokine CCL21, and loss or functional blockade of its receptors CCR7 and CXCR3 results in decreased CD8 T cell activation and recruitment, respectively, as well as prolonged survival. Thus, early detection of olfaction loss and blockade of pathological cell recruitment may offer potential therapeutic strategies for ECM.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24832450     DOI: 10.1016/j.chom.2014.04.008

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  30 in total

1.  MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Authors:  Brittany A Riggle; Sanhita Sinharay; William Schreiber-Stainthorp; Jeeva P Munasinghe; Dragan Maric; Eva Prchalova; Barbara S Slusher; Jonathan D Powell; Louis H Miller; Susan K Pierce; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.

Authors:  Matthew A Huggins; Holly L Johnson; Fang Jin; Aurelie N Songo; Lisa M Hanson; Stephanie J LaFrance; Noah S Butler; John T Harty; Aaron J Johnson
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

3.  Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.

Authors:  Daniel Fernandez-Ruiz; Lei Shong Lau; Nazanin Ghazanfari; Claerwen M Jones; Wei Yi Ng; Gayle M Davey; Dorothee Berthold; Lauren Holz; Yu Kato; Matthias H Enders; Ganchimeg Bayarsaikhan; Sanne H Hendriks; Lianne I M Lansink; Jessica A Engel; Megan S F Soon; Kylie R James; Anton Cozijnsen; Vanessa Mollard; Alessandro D Uboldi; Christopher J Tonkin; Tania F de Koning-Ward; Paul R Gilson; Tsuneyasu Kaisho; Ashraful Haque; Brendan S Crabb; Francis R Carbone; Geoffrey I McFadden; William R Heath
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

Review 4.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

5.  A distinct subpopulation of CD25- T-follicular regulatory cells localizes in the germinal centers.

Authors:  James Badger Wing; Yohko Kitagawa; Michela Locci; Hannah Hume; Christopher Tay; Takayoshi Morita; Yujiro Kidani; Kyoko Matsuda; Takeshi Inoue; Tomohiro Kurosaki; Shane Crotty; Cevayir Coban; Naganari Ohkura; Shimon Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-11       Impact factor: 11.205

6.  In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging.

Authors:  Angelika Hoffmann; Xavier Helluy; Manuel Fischer; Ann-Kristin Mueller; Sabine Heiland; Mirko Pham; Martin Bendszus; Johannes Pfeil
Journal:  J Vis Exp       Date:  2017-06-08       Impact factor: 1.355

7.  Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria.

Authors:  Ya Tian; Zhongyuan Zheng; Xi Wang; Shuzhi Liu; Liwei Gu; Jing Mu; Xiaojun Zheng; Yujie Li; Shuo Shen
Journal:  J Nanobiotechnology       Date:  2022-07-06       Impact factor: 9.429

8.  Measuring antigen presentation in mouse brain endothelial cells ex vivo and in vitro.

Authors:  Shanshan W Howland; Sin Yee Gun; Carla Claser; Chek Meng Poh; Laurent Rénia
Journal:  Nat Protoc       Date:  2015-11-12       Impact factor: 13.491

9.  Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.

Authors:  Kristina S Burrack; Matthew A Huggins; Emily Taras; Philip Dougherty; Christine M Henzler; Rendong Yang; Sarah Alter; Emily K Jeng; Hing C Wong; Martin Felices; Frank Cichocki; Jeffrey S Miller; Geoffrey T Hart; Aaron J Johnson; Stephen C Jameson; Sara E Hamilton
Journal:  Immunity       Date:  2018-04-03       Impact factor: 43.474

10.  Immune system challenge improves recognition memory and reverses malaria-induced cognitive impairment in mice.

Authors:  Luciana Pereira de Sousa; Flávia Lima Ribeiro-Gomes; Roberto Farina de Almeida; Tadeu Mello E Souza; Guilherme Loureiro Werneck; Diogo Onofre Souza; Cláudio Tadeu Daniel-Ribeiro
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.